• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

23andMe bankruptcy prompts Cornyn-Grassley-Klobuchar bipartisan bill to protect sensitive genetic data

by May 22, 2025
written by May 22, 2025

: Republican senators John Cornyn and Chuck Grassley and Democratic Sen. Amy Klobuchar are rolling out a bipartisan measure to protect sensitive genetic data in response to privacy concerns sparked by 23andMe’s bankruptcy, Fox News Digital has learned. 

Cornyn, R-Texas; Grassley, R-Iowa; and Klobuchar, D-Minn., are introducing the Don’t Sell My DNA Act, which would safeguard customers’ sensitive genetic information when an entity that maintains data files for bankruptcy. The bill would add genetic information to the definition of ‘personally identifiable information’ in the bankruptcy code. 

Under current law, the bankruptcy code provides protections for personally identifiable information in bankruptcy court proceedings to prevent the possibility of identity theft, harm or other unlawful injury. 

Senate aides told Fox News Digital the current definition of personally identifiable information includes an individual’s name, address, email, phone number, Social Security number, credit card numbers and other information that could be used for identification purposes. 

Those aides said the definition is ‘outdated’ and does not include a reference to genetic information, leaving the information vulnerable.

‘This legislation would solve this problem by updating the definition of ‘personally identifiable information’ in the bankruptcy code to include genetic information,’ a Senate aide said. 

The bill also addresses consumer privacy concerns by having consumers affirmatively consent to the sale or lease of their genetic information after a bankruptcy case commences and requiring companies to provide prior written notice of the use, sale or lease of their genetic information during bankruptcy. 

The bill also requires the trustee or debtor in possession to delete any genetic information not subject to a sale or lease. 

‘Advances in DNA testing have allowed Americans to have unprecedented access to important insights about their genetics, but these companies must have a plan to protect this data in the event of bankruptcy,’ Cornyn told Fox News Digital. 

‘By updating the bankruptcy code, this legislation would safeguard Americans’ sensitive genetic information to ensure it cannot be weaponized against them or made public without their knowledge and consent.’

And Klobuchar said companies ‘have profited off of Americans’ data while consumers have been left in the dark, which is especially concerning in light of reports that 23andMe plans to sell customer genetic data assets to a large pharmaceutical company.’ 

‘This bill will put new protections in place to safeguard Americans’ privacy while giving consumers greater control over how their sensitive health data is shared,’ Klobuchar said. 

Grassley told Fox News Digital consumers should ‘feel confident that any personal nformation shared with a public company isn’t up for grabs when that company files for bankruptcy.’

Grassley told Fox News Digital the bill ‘would fill gaps in current law to help safeguard consumers’ genetic information and ensure Americans’ DNA isn’t treated like any other financial asset.’ 

On Monday, 23andMe announced Regeneron Pharmaceuticals would purchase 23andMe through a bankruptcy auction. 

Senate aides said Regeneron promises to ‘protect consumer information, but the data privacy concerns for future bankruptcies remain.’ 

The genetic testing company 23andMe, once a pioneer in consumer DNA testing, filed for Chapter 11 bankruptcy in March amid financial struggles, a leadership shakeup and growing concerns about the security of its customers’ genetic data.

Regeneron Pharmaceuticals announced it will acquire ‘substantially all’ of genetic testing company 23andMe’s assets.

The pharmaceutical company said it won the court-supervised auction of the genetic testing company, with Regeneron agreeing to pay $256 million for the assets. The auction for 23andMe was part of the Chapter 11 bankruptcy protection it filed in March to arrange a sale of its business.

In its bankruptcy petition, the company estimated a range of $100 million to $500 million for its assets. Estimated liabilities were the same. 

The pharmaceutical company is buying 23andMe’s personal genome service and its health and research services segments, according to 23andMe. 

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
White House shuts down reporter’s ‘ridiculous’ challenge of White South African farmer deaths
next post
‘Half a dozen’ more states to ban soda, junk food purchases with food stamps, Trump Agriculture secretary says

related articles

CHARLIE KIRK: Republicans must seize Gen Z moment...

July 26, 2025

Europeans meet with Iranian officials face-to-face for first...

July 26, 2025

Trump’s executive order on birthright citizenship blocked by...

July 26, 2025

Michelle Obama portraitist’s exhibit with trans Statue of...

July 25, 2025

House Freedom Caucus conservative to enter race for...

July 25, 2025

Pelosi confident about Dems’ chances to win House,...

July 25, 2025

Pentagon freezes out DC think tanks in new...

July 25, 2025

Trump says SCOTUS immunity ruling likely helps Obama...

July 25, 2025

‘Louder by the hour’: Senate GOP wants the...

July 25, 2025

Grieving parents of American terror victim plead with...

July 25, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Trump celebrates conservative party win in Germany

    February 23, 2025
  • JOE CONCHA: ‘The Greatest Comeback Ever.’ How Trump won the White House all over again

    April 29, 2025
  • Harris touts growing up in middle class while pushing mandate most ‘won’t be able to afford’: economist

    October 22, 2024
  • AUDUSD and AUDNZD: AUDUSD is gaining support at  EMA 200

    September 2, 2024
  • Record-high gold prices keep Indian investors hooked—what’s next?

    February 21, 2025

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024
  • 3

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Biden calls to ‘lower the temperature’ then bashes Trump in NAACP speech

    July 17, 2024

Categories

  • Economy (829)
  • Editor's Pick (5,522)
  • Investing (634)
  • Stock (858)

Latest Posts

  • Trump inauguration performer Gavin DeGraw salutes ‘businessman running largest economy in world’

    January 23, 2025
  • Legal challenges on administrative reach expected in Trump’s deregulatory scheme, experts say

    November 27, 2024
  • US citizen imprisoned in Russia given new 15-year sentence in wake of espionage conviction

    December 25, 2024

Recent Posts

  • Homeland Security Secretary Kristi Noem hospitalized after allergic reaction

    June 17, 2025
  • Rick Scott knocked out of Senate leader race on first ballot as Thune and Cornyn advance

    November 13, 2024
  • S&P 500 and Nasdaq: Nasdaq rises to new high on Friday

    August 9, 2024

Editor’s Pick

  • Key GOP senator defects on crucial vote, imperiling Trump’s ‘big, beautiful bill’ in narrow majority

    June 28, 2025
  • Does Roblox Q2 earnings signal a gaming industry rebound?

    August 1, 2024
  • Tesla stock surges 4% ahead of Q1 earnings: what to expect

    April 22, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock